<p>Endocrine and neuroendocrine tumors originate from endocrine cells but are heterogeneous in terms of clinical presentation disease outcome and treatments available.</p><p>This Special Issue addresses specific aspects of pre-clinical clinical and translational research and clinical management of these diseases with the aim of providing novel insights addressing current unmet needs and discussing future treatment perspectives.</p>